Malignant Digestive System Neoplasm Clinical Trials

7 recruiting

Malignant Digestive System Neoplasm Trials at a Glance

8 actively recruiting trials for malignant digestive system neoplasm are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Houston, Branson, and Ann Arbor. Lead sponsors running malignant digestive system neoplasm studies include M.D. Anderson Cancer Center, Alliance for Clinical Trials in Oncology, and Emory University.

Browse malignant digestive system neoplasm trials by phase

Treatments under study

About Malignant Digestive System Neoplasm Clinical Trials

Looking for clinical trials for Malignant Digestive System Neoplasm? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Malignant Digestive System Neoplasm trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Malignant Digestive System Neoplasm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Molecular Epidemiology of Biliary Tree Cancers

CholangiocarcinomaMalignant Digestive System Neoplasm
M.D. Anderson Cancer Center1,500 enrolled1 locationNCT05179486
Recruiting

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

Malignant Female Reproductive System NeoplasmMalignant Genitourinary System NeoplasmMalignant Digestive System Neoplasm
Wake Forest University Health Sciences500 enrolled59 locationsNCT07215624
Recruiting
Not Applicable

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Esophageal CarcinomaGastric CarcinomaGastroesophageal Junction Carcinoma+7 more
Alliance for Clinical Trials in Oncology420 enrolled287 locationsNCT07283939
Recruiting
Phase 2

Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer

Malignant Female Reproductive System NeoplasmMalignant Digestive System Neoplasm
Mayo Clinic34 enrolled1 locationNCT06855524
Recruiting

Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers

Malignant Digestive System Neoplasm
M.D. Anderson Cancer Center150 enrolled1 locationNCT04629677
Recruiting

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Breast CarcinomaEsophageal CarcinomaHead and Neck Carcinoma+6 more
M.D. Anderson Cancer Center5,000 enrolled1 locationNCT00991094
Recruiting
Phase 2

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

Malignant Digestive System Neoplasm
Emory University60 enrolled3 locationsNCT03800693
Recruiting
Not Applicable

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

Metastatic Gastroesophageal Junction AdenocarcinomaMetastatic Hepatocellular CarcinomaStage IV Hepatocellular Carcinoma AJCC v8+41 more
University of California, San Francisco28 enrolled2 locationsNCT04221893